CLIENT RESULT

Eighteen days to final bid. Decision-ready in ten.

capabilities

Investment Diligence

Project Details

capability

Investment Diligence

Objective

A leading European healthcare PE firm had eighteen days to a final bid on a cell therapy reagents supplier. Carl's team produced a three-dimensional scenario framework that gave the deal team a full investment committee view with a week to spare.

Key Metrics

Our Approach

Outcome

Project Details

Project Timeline

Geographic Scope

Related Client Results

All Client Results

Cell Therapy Market Trends and Revenue Forecast

A cell therapy developer preparing for a NASDAQ listing needed financial projections, a valuation, and support on investor messaging

Revenue Projection

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Eighteen days to final bid. Decision-ready in ten.

A leading European healthcare PE firm had eighteen days to a final bid on a cell therapy reagents supplier. Carl's team produced a three-dimensional scenario framework that gave the deal team a full investment committee view with a week to spare.

Investment Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help